Stay updated on Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.
Latest updates to the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe study's location count has decreased from 257 to 256, with the latest update on January 16, 2025.SummaryDifference0.6%
- Check21 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check28 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check35 days agoChange DetectedA new Pembrolizumab biosimilar (RPH-075) has been added with an estimated last update posted on December 3, 2024, while previous updates from November 9 and 13, 2024, have been removed.SummaryDifference0.5%
- Check50 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check57 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the 'Contacts and Locations' section in the study record.SummaryDifference1%
Stay in the know with updates to Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Plus Radiation for Merkel Cell Carcinoma Clinical Trial page.